ARCTURUS THERAPEUTICS HOLDINGS INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-65.8M | $-80.9M | $-29.7M | $9.3M | $-203.7M | $-72.1M | $-26.0M | $-21.8M |
| Depreciation & Amortization | $3.0M | $3.5M | $3.0M | $1.5M | $1.2M | $882.0K | $684.0K | $582.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $25.4M | $38.0M | $34.6M | $30.6M | $28.9M | $6.8M | $2.0M | $1.3M |
| Net Cash from Operating Activities | $-74.3M | $-59.7M | $-18.1M | $32.0M | $-135.0M | $-42.9M | $-6.4M | $-20.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $230.0K | $648.0K | $2.9M | $7.7M | $3.4M | $1.7M | $818.0K | $1.5M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-230.0K | $-648.0K | $-2.9M | $-7.7M | $-3.4M | $-1.7M | $-818.0K | $22.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $13.4M | $5.4M | $-24.1M | $-2.9M | $48.0M | $436.1M | $41.9M | $10.2M |
| Net Change in Cash | $-61.1M | $-55.0M | $-45.1M | $21.4M | $-90.4M | $391.5M | $34.6M | $11.6M |
| Free Cash Flow | $-74.5M | $-60.4M | $-21.0M | $24.3M | $-138.4M | $-44.6M | $-7.3M | $-22.2M |